Literature DB >> 15338271

Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation.

Peter Teismann1, Jörg B Schulz.   

Abstract

Parkinson's disease (PD) is a frequent neurological disorder of the basal ganglia, which is characterized by the progressive loss of dopaminergic neurons mainly in the substantia nigra pars compacta (SNpc). Inflammatory processes have been shown to be associated with the pathogenesis of PD. Activated microglia, as well as to a lesser extent reactive astrocytes, are found in the area associated with cell loss, possibly contributing to the inflammatory process by the release of pro-inflammatory prostaglandins or cytokines. Further deleterious factors released by activated microglia or astrocytes are reactive oxygen species. On the other hand, they may mediate neuroprotective properties by the release of trophic factors or the uptake of glutamate. In this review, we will discuss the different aspects of activated glial cells and potential mechanisms that mediate or protect against cell loss in PD.

Entities:  

Mesh:

Year:  2004        PMID: 15338271     DOI: 10.1007/s00441-004-0944-0

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  119 in total

1.  Chronic dichlorvos exposure: microglial activation, proinflammatory cytokines and damage to nigrostriatal dopaminergic system.

Authors:  B K Binukumar; Amanjit Bal; Kiran Dip Gill
Journal:  Neuromolecular Med       Date:  2011-10-04       Impact factor: 3.843

2.  Targeting Dopamine in Acute Traumatic Brain Injury.

Authors:  James W Bales; Anthony E Kline; Amy K Wagner; C Edward Dixon
Journal:  Open Drug Discov J       Date:  2010

3.  Phosphatidylinositol 4-phosphate 5-kinase alpha is induced in ganglioside-stimulated brain astrocytes and contributes to inflammatory responses.

Authors:  Sang Yoon Lee; Bokyung Kim; Sarah Yoon; Yeon Joo Kim; Tian Liu; Joo Hong Woo; Yong-Joon Chwae; Eun-hye Joe; Ilo Jou
Journal:  Exp Mol Med       Date:  2010-09-30       Impact factor: 8.718

Review 4.  Toxicological and pathophysiological roles of reactive oxygen and nitrogen species.

Authors:  Ruth A Roberts; Robert A Smith; Stephen Safe; Csaba Szabo; Ronald B Tjalkens; Fredika M Robertson
Journal:  Toxicology       Date:  2010-07-17       Impact factor: 4.221

Review 5.  Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis.

Authors:  Tjalf Ziemssen
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

6.  Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice.

Authors:  Xiaofeng Xu; Ning Song; Ranran Wang; Hong Jiang; Junxia Xie
Journal:  Mol Neurobiol       Date:  2015-09-18       Impact factor: 5.590

7.  Tinospora cordifolia Suppresses Neuroinflammation in Parkinsonian Mouse Model.

Authors:  Hareram Birla; Sachchida Nand Rai; Saumitra Sen Singh; Walia Zahra; Arun Rawat; Neeraj Tiwari; Rakesh K Singh; Abhishek Pathak; Surya Pratap Singh
Journal:  Neuromolecular Med       Date:  2019-01-14       Impact factor: 3.843

8.  Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.

Authors:  Marianna Sikorska; Patricia Lanthier; Harvey Miller; Melissa Beyers; Caroline Sodja; Bogdan Zurakowski; Sandhya Gangaraju; Siyaram Pandey; Jagdeep K Sandhu
Journal:  Neurobiol Aging       Date:  2014-04-02       Impact factor: 4.673

9.  Systemic administration of lipopolysaccharide induces cyclooxygenase-2 immunoreactivity in endothelium and increases microglia in the mouse hippocampus.

Authors:  Dae Won Chung; Ki-Yeon Yoo; In Koo Hwang; Dae Won Kim; Jin Young Chung; Choong Hyun Lee; Jung Hoon Choi; Soo Young Choi; Hwa Young Youn; In Se Lee; Moo-Ho Won
Journal:  Cell Mol Neurobiol       Date:  2009-11-12       Impact factor: 5.046

10.  PEGylated rhFGF-2 conveys long-term neuroprotection and improves neuronal function in a rat model of Parkinson's disease.

Authors:  Guanghui Zhu; Ganping Chen; Lu Shi; Jenny Feng; Yan Wang; Chaohui Ye; Wenke Feng; Jianlou Niu; Zhifeng Huang
Journal:  Mol Neurobiol       Date:  2014-06-15       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.